SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027565
Filing Date
2018-11-07
Accepted
2018-11-06 17:56:15
Documents
98
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q-20180930 mygn-10q_20180930.htm 10-Q 2201897
2 EX-10.1 FORM OF EXECUTIVE RETENTION AGREEMENT mygn-ex101_57.htm EX-10.1 110523
3 EX-10.2 FORM OF INDEMNIFICATION AGREEMENT mygn-ex102_56.htm EX-10.2 69988
4 EX-31.1 mygn-ex311_8.htm EX-31.1 15856
5 EX-31.2 mygn-ex312_7.htm EX-31.2 16324
6 EX-32.1 mygn-ex321_6.htm EX-32.1 6533
  Complete submission text file 0001564590-18-027565.txt   10385312

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mygn-20180930.xml EX-101.INS 2777723
8 XBRL TAXONOMY EXTENSION SCHEMA mygn-20180930.xsd EX-101.SCH 63679
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20180930_cal.xml EX-101.CAL 74499
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20180930_def.xml EX-101.DEF 200944
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20180930_lab.xml EX-101.LAB 459489
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20180930_pre.xml EX-101.PRE 376496
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 181164148
SIC: 2835 In Vitro & In Vivo Diagnostic Substances